Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma

por Caimi, Paolo F., Pacheco Sanchez, Gabriela, Sharma, Ashish, Otegbeye, Folashade, Ahmed, Nausheen, Rojas, Patricio, Patel, Seema, Kleinsorge Block, Sarah, Schiavone, Jennifer, Zamborsky, Kayla, Boughan, Kirsten, Hillian, Antoinette, Reese-Koc, Jane, Maschan, Mikhail, Dropulic, Boro, Sekaly, Rafick-Pierre, de Lima, Marcos
Publicado 2021

In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells

por Anthony-Gonda, Kim, Ray, Alex, Su, Hang, Wang, Yuge, Xiong, Ying, Lee, Danica, Block, Ariele, Chilunda, Vanessa, Weiselberg, Jessica, Zemelko, Lily, Wang, Yen Y., Kleinsorge-Block, Sarah, Reese, Jane S., de Lima, Marcos, Ochsenbauer, Christina, Kappes, John C., Dimitrov, Dimiter S., Orentas, Rimas, Deeks, Steven G., Rutishauser, Rachel L., Berman, Joan W., Goldstein, Harris, Dropulić, Boro
Publicado 2022

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma

por Jackson, Zachary, Roe, Anne, Sharma, Ashish Arunkumar, Lopes, Filipa Blasco Tavares Pereira, Talla, Aarthi, Kleinsorge-Block, Sarah, Zamborsky, Kayla, Schiavone, Jennifer, Manjappa, Shivaprasad, Schauner, Robert, Lee, Grace, Liu, Ruifu, Caimi, Paolo F., Xiong, Ying, Krueger, Winfried, Worden, Andrew, Kadan, Mike, Schneider, Dina, Orentas, Rimas, Dropulic, Boro, Sekaly, Rafick-Pierre, de Lima, Marcos, Wald, David N., Reese, Jane S.
Publicado 2020